Geocann and Pathway Health form strategic partnership to


FORT COLLINS, Colorado, January 27, 2021 (GLOBE NEWSWIRE) – Geocann is proud to announce a strategic partnership with Pathway Health Corp. (“PHC”) which will place VESIsorb® formulated products at the forefront of the rapidly evolving medical cannabis programs of major Canadian pharmacies. PHC, formerly The Clinic Network Canada Inc., owns and operates the largest chronic pain telehealth network in Canada, and recently expanded its business model by entering into agreements with some of the largest national retail pharmacy companies. . Key elements of these agreements include a full service collaboration, from training programs for pharmacists to patient realization of medical cannabis products.

“We are delighted to enter into an agreement with PHC that will provide access to our portfolio of VESIsorb® formulated medical cannabis to millions of Canadians,” said Jesse Lopez, CEO and Founder of Geocann. “With its new business initiatives, PHC has quickly become the premier reference site for pain products and services for thousands of drugstores. PHC’s expertise in reaching the end consumer through its strategic pharmaceutical partnerships will fit perfectly with the significant investments that Geocann has made in product safety, purity and performance.

“Geocann’s portfolio of medical cannabis products has set the benchmark for what pharmacists demand and health-conscious consumers expect,” said Michael Steele, CEO of PHC. “The unparalleled supporting scientific evidence for VESIsorb® products has provided the platform necessary to develop, co-brand and distribute specialty cannabis products to our nationwide footprint of leading pharmacies and pain clinics. “

Geocann is well known for its substantial investments in research to meet changing global market demands and deliver significant product differentiation to leading lifestyle and medical brands around the world. In addition to recent pharmacokinetic studies (Molecules 2019, 24 (16), 2967) and stability data for its products, further investments in new clinical research focused on both pharmacokinetic performance and clinical parameters are underway. In addition, several toxicological studies have been performed and will be published this year as part of the FDA GRAS (Generally Considered Safe) notification and the company’s novel food application.

Geocann and PHC are also focusing on training initiatives that will reach approximately 42,000 licensed pharmacists working in more than 10,000 pharmacies. These include traditional bilingual programs accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) and integration tools such as the Medical Cannabis Management Program for Pharmacists.

“Preparing pharmacy professionals to take an active role in the medical cannabis market is a top priority for PHC,” said Steele. “Health conscious consumers depend on their pharmacies to provide clinically researched and proven products in addition to knowledgeable recommendations and advice for the products they offer. Our partnership with Geocann gives us an unparalleled ability to offer these elements.

Geocann owns the exclusive worldwide rights to the patented drug delivery technology VESIsorb® for cannabinoid, terpene and flavonoid formulations. The technology has been successfully applied to a wide range of medical cannabis product applications, including soft and hard capsules, functional foods (e.g. gummy candies) and beverages, powder systems. , tinctures, sublingual sprays and topically applied formulations.

About Geocann
Geocann is a global cannabis organization led by experienced leadership with scientific and technical expertise to launch new innovations in natural health products and solutions. Its goal is to combine clinically researched cannabinoids with technologically advanced and patented innovations that differentiate products with superior therapeutic performance and unmatched supporting evidence. Geocann has a strong intellectual property portfolio, including the worldwide exclusivity of cannabinoids, terpenes and flavonoids formulated with VESIsorb®. For more information, please visit

For more information and interview requests, please contact Sam Davidson at 970-657-2479 or [email protected]

About Pathway Health Corp.

PHC is one of the largest providers of out-of-hospital pain management services in Canada. PHC operates the largest national medical cannabis telehealth network, as well as the ownership and operation of nine community clinics in four provinces. PHC’s patient care programs use an interdisciplinary approach and are supported by qualified pain specialists, physiotherapists and occupational therapists, psychologists, nurses and other health care providers. PHC has also developed expertise in harm reduction where medicinal cannabis and other modalities are used as alternatives to traditional opioids. As part of these initiatives, PHC quickly became the primary reference site for pain products and services for thousands of pharmacies across Canada.

For more information and interview requests, please contact Wayne Cockburn, President at 905-505-0770 or [email protected]


Comments are closed.